Prognostic role of EAONO/JOS, STAMCO, and ChOLE Staging for Exclusive Endoscopic and Endoscopic-Microscopic Tympanoplasty.
cholesteatoma
cholesteatoma staging
endoscopic ear surgery
recurrence
residual cholesteatoma
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
13
09
2022
received:
25
07
2022
accepted:
15
09
2022
medline:
28
3
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
The aim of the study is to evaluate cholesteatoma's surgical outcomes in patients treated with endoscopic ear surgery (EES) or a combined endoscopic-microscopic approach (cEMA) according to STAM, STAMCO, ChOLE, and EAONO/JOS system (EJS) classifications and staging. Retrospective study. Monocentric study in a tertiary referral center. One-hundred sixty-eight patients who underwent EES or cEMA for cholesteatoma between 2010 and 2018 were classified according to the abovementioned classification and staging. Data on cholesteatoma's recurrence and residual rates were collected. Inferential statistical analysis was performed to evaluate surgical outcomes and the prognostic value of classifications and staging. The recurrence rate was significantly lower in cholesteatomas classified in EJS stage 1 (2.6%) and STAM stage 1 (0%). A comparison of the different stages of the disease showed a significantly lower recurrence only for stage 1 versus the superior stages of both classifications. Involvement of mastoid bone was associated with a higher risk of recurrence (odds ratio [OR]: 4.12; p = .031). Attical involvement was associated with a higher risk of residual cholesteatoma (OR: 1.165; p = .046). EES or cEMA represents an effective treatment for middle ear cholesteatoma. The STAM classification and the EJS have shown a prognostic value, with STAM 1 and EAONO-JOS 1 stages associated with a better prognosis. Mastoid involvement represents a risk factor for recurrence. Attic localization is associated with residual disease. Localization at difficult access sites did not implicate a higher risk for recurrence or residual. ChOLE classification, Ossicular chain status, and complication status did not provide prognostic information regarding recurrence or residual cholesteatoma.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
829-838Informations de copyright
© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Tarabichi M. Endoscopic management of cholesteatoma: long-term results. Otolaryngol Head Neck Surg. 2000;122(6):874-881. doi:10.1016/S0194-5998(00)70017-9
Presutti L, Gioacchini FM, Alicandri-Ciufelli M, Villari D, Marchioni D. Results of endoscopic middle ear surgery for cholesteatoma treatment: a systematic review. Acta Otorhinolaryngol Ital. 2014;34(3):153-157.
Bonali M, Fermi M, Alicandri-Ciufelli M, et al. Correlation of radiologic versus endoscopic visualization of the middle ear: implications for endoscopic ear surgery. Otol Neurotol. 2020;41(9):1122. doi:10.1097/MAO.0000000000002787
Anschuetz L, Alicandri-Ciufelli M, Bonali M, et al. Novel surgical and radiologic classification of the subtympanic sinus: implications for endoscopic ear surgery. Otolaryngol Head Neck Surg. 2018;159(6):1037-1042. doi:10.1177/0194599818787180
Marchioni D, Mattioli F, Alicandri-Ciufelli M, Molteni G, Masoni F, Presutti L. Endoscopic evaluation of middle ear ventilation route blockage. Am J Otolaryngol. 2010;31(6):453-466. doi:10.1016/j.amjoto.2009.08.010
van der Toom H, van der Schroeff MP, Janssen J, Westzaan AM, Pauw RJ. A retrospective analysis and comparison of the STAM and STAMCO classification and EAONO/JOS cholesteatoma staging system in predicting surgical treatment outcomes of middle ear cholesteatoma. Otol Neurotol. 2020;41(4):468. doi:10.1097/MAO.0000000000002549
Merkus P, Tije FA, Stam M, Tan FML, Pauw RJ. Implementation of the “EAONO/JOS definitions and classification of middle ear cholesteatoma”-from STAM to STAMCO. J Int Adv Otol. 2017;13(2):272-275. doi:10.5152/iao.2017.4049
Linder TE, Shah S, Martha AS, Röösli C, Emmett SD. Introducing the “ChOLE” classification and its comparison to the EAONO/JOS consensus classification for cholesteatoma staging. Otol Neurotol. 2019;40(1):63-72. doi:10.1097/MAO.0000000000002039
Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol. 2017;13(1):1-8. doi:10.5152/iao.2017.3363
Fernandez IJ, Bonali M, Fermi M, Ghirelli M, Villari D, Presutti L. The role of endoscopic stapes surgery in difficult oval window niche anatomy. Eur Arch Otrhinolaryngol. 2019;276(7):1897-1905. doi:10.1007/s00405-019-05401-z
Fernandez IJ, Botti C, Fermi M, Presutti L. Endoscopic management of malleus head fixation in revision stapes surgery. Otol Neurotol. 2020;41(5):614-617. doi:10.1097/MAO.0000000000002592
James AL, Tono T, Cohen MS, et al. International collaborative assessment of the validity of the EAONO-JOS cholesteatoma staging system. Otol Neurotol. 2019;40(5):630-637. doi:10.1097/MAO.0000000000002168
Arsovic N, Djeric D, Petrovic Z, Djordjevic V, Krejovic-Trivic S, Djukic V. Etiopathogenetic aspects of recurrent cholesteatoma development. Int Congr Ser. 2003;1240:37-42. doi:10.1016/S0531-5131(03)00789-1
Eggink MC, de Wolf MJF, Ebbens FA, Dikkers FG, van Spronsen E. Evaluation of long-term cholesteatoma recidivism: using the JOS, EAONO-JOS, and STAMCO cholesteatoma staging systems. Otol Neurotol. 2021;42(7):1031-1038.
Bächinger D, Rrahmani A, Weiss NM, Mlynski R, Huber A, Röösli C. Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system. Eur Arch Otrhinolaryngol. 2021;278(5):1365-1371. doi:10.1007/s00405-020-06208-z
Fina M, Chieffe D. Office-based otology procedures. Otolaryngol Clin North Am. 2019;52(3):497-507. doi:10.1016/j.otc.2019.02.004
Gaillardin L, Lescanne E, Morinière S, Cottier JP, Robier A. Residual cholesteatoma: prevalence and location. Follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(3):136-140. doi:10.1016/j.anorl.2011.01.009
Rayneau P, Aussedat C, Trinh TT, et al. Influence of surgical technique on residual cholesteatoma location and prevalence. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(1):13-16. doi:10.1016/j.anorl.2019.09.011
Hu Y, Teh BM, Hurtado G, Yao X, Huang J, Shen Y. Can endoscopic ear surgery replace microscopic surgery in the treatment of acquired cholesteatoma? A contemporary review. Int J Pediatr Otorhinolaryngol. 2020;131:109872. doi:10.1016/j.ijporl.2020.109872
Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol. 2013;18(3):135-142. doi:10.1159/000346140
Kerckhoffs KGP, Kommer MBJ, van Strien THL, et al. The disease recurrence rate after the canal wall up or canal wall down technique in adults: a review on cholesteatoma recidivism after CWU and CWD. Laryngoscope. 2016;126(4):980-987. doi:10.1002/lary.25591
Li B, Zhou L, Wang M, Wang Y, Zou J. Endoscopic versus microscopic surgery for treatment of middle ear cholesteatoma: a systematic review and meta-analysis. Am J Otolaryngol. 2021;42(2):102451. doi:10.1016/j.amjoto.2020.102451
Lucidi D, Reale M, Fermi M, et al. Disease-specific quality of life and psychological distress after endoscopic tympanoplasty. Eur Arch Otrhinolaryngol. 2021;279:191-198. doi:10.1007/s00405-021-06670-3